Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Swecure AB

Prophylactic allergy prevention

This article was originally published in Start Up

Executive Summary

There are many treatments on the market and in development that ease the symptoms of allergies, from antihistamines to immunotherapies, but there is no real prevention or cure. Swedish biotech Swecure AB aims to prevent the development of allergies in the first place: its research is based on a bacterial protein, known as a superantigen, found in the gut flora of newborn babies.

Advertisement

Related Content

Biopharma In Sweden: A Comfortable Climate For Start-Ups
Biopharma In Sweden: A Comfortable Climate For Start-Ups

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC092640

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel